nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00216	0.00216	CcSEcCtD
Verteporfin—Nervous system disorder—Vinorelbine—ovarian cancer	0.00215	0.00215	CcSEcCtD
Verteporfin—Pain—Melphalan—ovarian cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Skin disorder—Vinorelbine—ovarian cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00212	0.00212	CcSEcCtD
Verteporfin—Feeling abnormal—Topotecan—ovarian cancer	0.00211	0.00211	CcSEcCtD
Verteporfin—Haemoglobin—Paclitaxel—ovarian cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Haemorrhage—Paclitaxel—ovarian cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Asthenia—Chlorambucil—ovarian cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Pharyngitis—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Pruritus—Chlorambucil—ovarian cancer	0.00203	0.00203	CcSEcCtD
Verteporfin—Urticaria—Topotecan—ovarian cancer	0.00203	0.00203	CcSEcCtD
Verteporfin—Body temperature increased—Topotecan—ovarian cancer	0.00202	0.00202	CcSEcCtD
Verteporfin—Dry eye—Doxorubicin—ovarian cancer	0.00202	0.00202	CcSEcCtD
Verteporfin—Visual impairment—Paclitaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.002	0.002	CcSEcCtD
Verteporfin—Urticaria—Melphalan—ovarian cancer	0.00199	0.00199	CcSEcCtD
Verteporfin—Pneumonia—Docetaxel—ovarian cancer	0.00197	0.00197	CcSEcCtD
Verteporfin—Dyspnoea—Vinorelbine—ovarian cancer	0.00195	0.00195	CcSEcCtD
Verteporfin—Photosensitivity—Epirubicin—ovarian cancer	0.00195	0.00195	CcSEcCtD
Verteporfin—Eye disorder—Paclitaxel—ovarian cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00193	0.00193	CcSEcCtD
Verteporfin—Cardiac disorder—Paclitaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Verteporfin—Flushing—Paclitaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Verteporfin—Myocardial infarction—Docetaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Verteporfin—Eczema—Epirubicin—ovarian cancer	0.00191	0.00191	CcSEcCtD
Verteporfin—Conjunctivitis—Docetaxel—ovarian cancer	0.0019	0.0019	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Hypersensitivity—Topotecan—ovarian cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Angiopathy—Paclitaxel—ovarian cancer	0.00188	0.00188	CcSEcCtD
Verteporfin—Constipation—Vinorelbine—ovarian cancer	0.00187	0.00187	CcSEcCtD
Verteporfin—Pain—Vinorelbine—ovarian cancer	0.00187	0.00187	CcSEcCtD
Verteporfin—Immune system disorder—Paclitaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Verteporfin—Hypersensitivity—Melphalan—ovarian cancer	0.00185	0.00185	CcSEcCtD
Verteporfin—Asthenia—Topotecan—ovarian cancer	0.00184	0.00184	CcSEcCtD
Verteporfin—Pruritus—Topotecan—ovarian cancer	0.00181	0.00181	CcSEcCtD
Verteporfin—Photosensitivity—Doxorubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Verteporfin—Malnutrition—Paclitaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Feeling abnormal—Vinorelbine—ovarian cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Asthenia—Melphalan—ovarian cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Dermatitis bullous—Epirubicin—ovarian cancer	0.00179	0.00179	CcSEcCtD
Verteporfin—Pruritus—Melphalan—ovarian cancer	0.00177	0.00177	CcSEcCtD
Verteporfin—Haemoglobin—Docetaxel—ovarian cancer	0.00177	0.00177	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Haemorrhage—Docetaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Hypoaesthesia—Docetaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Back pain—Paclitaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Pharyngitis—Docetaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Verteporfin—Urticaria—Vinorelbine—ovarian cancer	0.00174	0.00174	CcSEcCtD
Verteporfin—Body temperature increased—Vinorelbine—ovarian cancer	0.00173	0.00173	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Verteporfin—Nausea—Chlorambucil—ovarian cancer	0.00171	0.00171	CcSEcCtD
Verteporfin—Vision blurred—Paclitaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Verteporfin—Visual impairment—Docetaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Dizziness—Topotecan—ovarian cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Verteporfin—Anaemia—Paclitaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Verteporfin—Eye disorder—Docetaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Flushing—Docetaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Cardiac disorder—Docetaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Malaise—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Vertigo—Paclitaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Syncope—Paclitaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Rash—Topotecan—ovarian cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Dermatitis—Topotecan—ovarian cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Headache—Topotecan—ovarian cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Angiopathy—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Immune system disorder—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Loss of consciousness—Paclitaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Rash—Melphalan—ovarian cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Dermatitis—Melphalan—ovarian cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Cough—Paclitaxel—ovarian cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Asthenia—Vinorelbine—ovarian cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Hypertension—Paclitaxel—ovarian cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Pruritus—Vinorelbine—ovarian cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Chest pain—Paclitaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Arthralgia—Paclitaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Malnutrition—Docetaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Nausea—Topotecan—ovarian cancer	0.00152	0.00152	CcSEcCtD
Verteporfin—Discomfort—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Nausea—Melphalan—ovarian cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Influenza—Epirubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Back pain—Docetaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Oedema—Paclitaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Shock—Paclitaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Dizziness—Vinorelbine—ovarian cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Skin disorder—Paclitaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Verteporfin—Anaemia—Docetaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Rash—Vinorelbine—ovarian cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Dermatitis—Vinorelbine—ovarian cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Headache—Vinorelbine—ovarian cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Syncope—Docetaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—ovarian cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Loss of consciousness—Docetaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Cough—Docetaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Verteporfin—Hypertension—Docetaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Dyspnoea—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Verteporfin—Chest pain—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Arthralgia—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Nausea—Vinorelbine—ovarian cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Sweating—Epirubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Pain—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Verteporfin—Constipation—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Oedema—Docetaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Verteporfin—Shock—Docetaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Verteporfin—Nervous system disorder—Docetaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Skin disorder—Docetaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Urticaria—Paclitaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Body temperature increased—Paclitaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Dyspnoea—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Flushing—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Constipation—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Pain—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Asthenia—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Pruritus—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Feeling abnormal—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Back pain—Epirubicin—ovarian cancer	0.000998	0.000998	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—ovarian cancer	0.000995	0.000995	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—ovarian cancer	0.000991	0.000991	CcSEcCtD
Verteporfin—Body temperature increased—Docetaxel—ovarian cancer	0.000987	0.000987	CcSEcCtD
Verteporfin—Dizziness—Paclitaxel—ovarian cancer	0.000974	0.000974	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—ovarian cancer	0.000972	0.000972	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000957	0.000957	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—ovarian cancer	0.000955	0.000955	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—ovarian cancer	0.000954	0.000954	CcSEcCtD
Verteporfin—Malaise—Epirubicin—ovarian cancer	0.00093	0.00093	CcSEcCtD
Verteporfin—Rash—Paclitaxel—ovarian cancer	0.000929	0.000929	CcSEcCtD
Verteporfin—Dermatitis—Paclitaxel—ovarian cancer	0.000928	0.000928	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—ovarian cancer	0.000927	0.000927	CcSEcCtD
Verteporfin—Syncope—Epirubicin—ovarian cancer	0.000925	0.000925	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—ovarian cancer	0.000923	0.000923	CcSEcCtD
Verteporfin—Headache—Paclitaxel—ovarian cancer	0.000923	0.000923	CcSEcCtD
Verteporfin—Hypersensitivity—Docetaxel—ovarian cancer	0.00092	0.00092	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—ovarian cancer	0.000907	0.000907	CcSEcCtD
Verteporfin—Cough—Epirubicin—ovarian cancer	0.0009	0.0009	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—ovarian cancer	0.0009	0.0009	CcSEcCtD
Verteporfin—Asthenia—Docetaxel—ovarian cancer	0.000896	0.000896	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—ovarian cancer	0.000891	0.000891	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000886	0.000886	CcSEcCtD
Verteporfin—Pruritus—Docetaxel—ovarian cancer	0.000883	0.000883	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—ovarian cancer	0.000882	0.000882	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—ovarian cancer	0.000878	0.000878	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—ovarian cancer	0.000878	0.000878	CcSEcCtD
Verteporfin—Nausea—Paclitaxel—ovarian cancer	0.000875	0.000875	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—ovarian cancer	0.000868	0.000868	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—ovarian cancer	0.000861	0.000861	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—ovarian cancer	0.000858	0.000858	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—ovarian cancer	0.000856	0.000856	CcSEcCtD
Verteporfin—Oedema—Epirubicin—ovarian cancer	0.000842	0.000842	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000839	0.000839	CcSEcCtD
Verteporfin—Cough—Doxorubicin—ovarian cancer	0.000833	0.000833	CcSEcCtD
Verteporfin—Shock—Epirubicin—ovarian cancer	0.000828	0.000828	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—ovarian cancer	0.000826	0.000826	CcSEcCtD
Verteporfin—Dizziness—Docetaxel—ovarian cancer	0.000826	0.000826	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—ovarian cancer	0.000824	0.000824	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—ovarian cancer	0.000818	0.000818	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000814	0.000814	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—ovarian cancer	0.000813	0.000813	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—ovarian cancer	0.000813	0.000813	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000807	0.000807	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Verteporfin—Rash—Docetaxel—ovarian cancer	0.000787	0.000787	CcSEcCtD
Verteporfin—Dermatitis—Docetaxel—ovarian cancer	0.000786	0.000786	CcSEcCtD
Verteporfin—Headache—Docetaxel—ovarian cancer	0.000782	0.000782	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—ovarian cancer	0.000779	0.000779	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000767	0.000767	CcSEcCtD
Verteporfin—Shock—Doxorubicin—ovarian cancer	0.000767	0.000767	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000764	0.000764	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—ovarian cancer	0.000757	0.000757	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000753	0.000753	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—ovarian cancer	0.000751	0.000751	CcSEcCtD
Verteporfin—Nausea—Docetaxel—ovarian cancer	0.000742	0.000742	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000727	0.000727	CcSEcCtD
Verteporfin—Pain—Epirubicin—ovarian cancer	0.00072	0.00072	CcSEcCtD
Verteporfin—Constipation—Epirubicin—ovarian cancer	0.00072	0.00072	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—ovarian cancer	0.000695	0.000695	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—ovarian cancer	0.000694	0.000694	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—ovarian cancer	0.000669	0.000669	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Verteporfin—Pain—Doxorubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000642	0.000642	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—ovarian cancer	0.00062	0.00062	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—ovarian cancer	0.000619	0.000619	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—ovarian cancer	0.000616	0.000616	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—ovarian cancer	0.000596	0.000596	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000574	0.000574	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—ovarian cancer	0.000559	0.000559	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—ovarian cancer	0.000557	0.000557	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—ovarian cancer	0.000551	0.000551	CcSEcCtD
Verteporfin—Rash—Epirubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—ovarian cancer	0.00053	0.00053	CcSEcCtD
Verteporfin—Headache—Epirubicin—ovarian cancer	0.000528	0.000528	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Verteporfin—Nausea—Epirubicin—ovarian cancer	0.0005	0.0005	CcSEcCtD
Verteporfin—Rash—Doxorubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Verteporfin—Headache—Doxorubicin—ovarian cancer	0.000488	0.000488	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—ovarian cancer	0.000463	0.000463	CcSEcCtD
